Literature DB >> 19699067

Impact of chitosan coating of anionic liposomes on clearance rate, mucosal and systemic immune responses following nasal administration in rabbits.

Mohamadreza Amin1, Mahmoud Reza Jaafari, Mohsen Tafaghodi.   

Abstract

Liposomes have been identified as effective immunological adjuvants and have potential for the intranasal and oral delivery of protein antigen. Anionic MLV liposomes were prepared by dehydration-rehydration method. For coating, liposomes were incubated in chitosan solution. Efficiency of coating was confirmed by the evaluation of FITC-labelled chitosan-coated liposomes using a fluorescent microscope. Liposomes morphology and size were studied by optical microscope and size analyzer. Mucoadhesion potential of liposomes was evaluated in human nose by gamma-scintigraphy using (99m)Tc-labelled liposomes. Rabbits (4 animals per group) were nasally immunized in weeks 0, 2 and 4 by liposomes encapsulated with 40 Lf TT. Bleedings and lavage collections were taken place in weeks 3 and 6, and IgG and sIgA titers were measured by ELISA method. Liposomes had a mean diameter of 2.38 microm. Loading of TT was 58.7+/-12.4%. The mucoadhesion (clearance rate from nose) of both coated and non-coated liposomes was similar (P>0.05). Among the immunized animals, the highest nasal lavage sIgA titers were seen in non-coated liposomes followed by coated ones. The serum IgG titers (2nd bleeding) in animals immunized by both kinds of liposome were similar (P>0.05), and were lower than the TT solution group (P<0.05). Immunization by i.m. injection of TT solution resulted in the lowest sIgA and highest IgG titers (P<0.05) compared with liposomal groups. The results were indicative of good potential of negatively charged liposomes in the induction of mucosal immunity. Coating of liposomes by chitosan, failed to increase both the residence time of liposomes in nasal cavity and systemic responses. Conversely, coated liposomes could not induce the mucosal responses as efficiently as non-coated liposomes. It seems that the coating of liposomes affected their interaction potential with nasal associated lymphoid tissue cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699067     DOI: 10.1016/j.colsurfb.2009.07.024

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  13 in total

1.  Novel antigen delivery technologies: a review.

Authors:  Deepika Jain; Vikas Jain; Ranjit Singh
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

Review 2.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

Review 3.  Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art.

Authors:  Mohammad A S Abourehab; Rahul R Rajendran; Anshul Singh; Sheersha Pramanik; Prachi Shrivastav; Mohammad Javed Ansari; Ravi Manne; Larissa Souza Amaral; A Deepak
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

Review 4.  Enhancing oral vaccine potency by targeting intestinal M cells.

Authors:  Ali Azizi; Ashok Kumar; Francisco Diaz-Mitoma; Jiri Mestecky
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

5.  Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt.

Authors:  Peipei Guan; Yi Lu; Jianping Qi; Mengmeng Niu; Ruyue Lian; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2011-05-04

6.  Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties.

Authors:  Kerstin Gradauer; Caroline Vonach; Gerd Leitinger; Dagmar Kolb; Eleonore Fröhlich; Eva Roblegg; Andreas Bernkop-Schnürch; Ruth Prassl
Journal:  Int J Nanomedicine       Date:  2012-05-21

7.  Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid.

Authors:  Faezeh Moghadam Ariaee; Mohsen Tafaghodi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 8.  Mucosal Vaccine Development Based on Liposome Technology.

Authors:  Valentina Bernasconi; Karin Norling; Marta Bally; Fredrik Höök; Nils Y Lycke
Journal:  J Immunol Res       Date:  2016-12-29       Impact factor: 4.818

9.  The mucosal adjuvant potential of cross-linked dextran microspheres as dry powder.

Authors:  Mohsen Tafaghodi; Maryam Eskandari
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

10.  Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.

Authors:  M J Barea; M J Jenkins; Y S Lee; P Johnson; R H Bridson
Journal:  Int J Biomater       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.